Genetic polymorphism in exon 2 of cathepsin D is not associated with vascular dementia

Acta Neurologica Scandinavica

Volumn 123, Issue 6, 2011, Pages 419-423

  Jeong, B H ^a   Lee, K H ^b   Lee, Y J ^a   Yun, J ^a   Park, Y J ^a   Kim, Y H ^b   Cho, Y S ^b   Choi, E K ^a   Carp, R I ^c   Kim, Y S ^a  

^a Hallym University   (South Korea)

^b Samkwang Medical Laboratories   (South Korea)

^c NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Alzheimer's disease; Cathepsin D; Population genetics; Single nucleotide polymorphism; Vascular dementia

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CATHEPSIN D;

AGED; ALZHEIMER DISEASE; ARTICLE; ASIAN; CONTROLLED STUDY; CTSD GENE; EUROPE; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA;

AGED; AGED, 80 AND OVER; CATHEPSIN D; DEMENTIA, VASCULAR; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79954474337     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2010.01400.x     Document Type: Article

References (37)

1. Roman GC. Vascular dementia: distinguishing characteristics, treatment, and prevention. J Am Geriatr Soc 2003;51:S296-304.
2. Di Carlo A, Baldereschi M, Amaducci L et al. Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study. J Am Geriatr Soc 2002;50:41-8.
3. Yi S, Suh C, Park Y, Park J. Causative diseases of 108 dementia patients. Kor J Neurol 1988;6:234-9.
4. Woo JI, Lee JH, Yoo KY et al. Prevalence estimation of dementia in a rural area of Korea. J Am Geriatr Soc 1998;46:983-7.
5. Urakami K, Adachi Y, Wakutani Y et al. Epidemiologic and genetic studies of dementia of the Alzheimer type in Japan. Dement Geriatr Cogn Disord 1998;9:294-8.
6. Hassan A, Markus HS. Genetics and ischaemic stroke. Brain 2000;123:1784-812.
7. Vural P, Deǧirmencioǧlu S, Parildar-Karpuzoǧlu H et al. The combinations of TNFalpha-308 and IL-6 -174 or IL-10 -1082 genes polymorphisms suggest an association with susceptibility to sporadic late-onset Alzheimer's disease. Acta Neurol Scand 2009;120:396-401.
8. Benes P, Vetvicka V, Fusek M. Cathepsin D--many functions of one aspartic protease. Crit Rev Oncol Hematol 2008;68:12-28.
9. Cataldo AM, Barnett JL, Pieroni C, Nixon RA. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis. J Neurosci 1997;17:6142-51.
10. Chevallier N, Vizzavona J, Marambaud P et al. Cathepsin D displays in vitro beta-secretase-like specificity. Brain Res 1997;750:11-9.
11. Touitou I, Capony F, Brouillet JP, Rochefort H. Missense polymorphism (C/T224) in the human cathepsin D pro-fragment determined by polymerase chain reaction--single strand conformational polymorphism analysis and possible consequences in cancer cells. Eur J Cancer 1994;30A:390-4.
12. Papassotiropoulos A, Bagli M, Feder O et al. Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease. Neurosci Lett 1999;262:171-4.
13. Davidson Y, Gibbons L, Pritchard A et al. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype. J Neurol Neurosurg Psychiatry 2006;77:515-7.
14. Bhojak TJ, DeKosky ST, Ganguli M, Kamboh MI. Genetic polymorphisms in the cathepsin D and interleukin-6 genes and the risk of Alzheimer's disease. Neurosci Lett 2000;288:21-4.
15. Emahazion T, Feuk L, Jobs M et al. SNP association studies in Alzheimer's disease highlight problems for complex disease analysis. Trends Genet 2001;17:407-13.
16. Prince JA, Feuk L, Sawyer SL et al. Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease. Eur J Hum Genet 2001;9:437-44.
17. Mateo I, Sánchez-Guerra M, Combarros O et al. Lack of association between cathepsin D genetic polymorphism and Alzheimer disease in a Spanish sample. Am J Med Genet 2002;114:31-3.
18. Capurso C, Solfrizzi V, D'Introno A et al. Short arm of chromosome 11 and sporadic Alzheimer's disease: catalase and cathepsin D gene polymorphisms. Neurosci Lett 2008;432:237-42.
19. Styczynska M, Religa D, Pfeffer A et al. Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimer's disease. Neurosci Lett 2003;344:99-102.
20. Li XQ, Chen D, Zhang ZX, Qu QM, Zhang JW. Association between cathepsin D polymorphism and Alzheimer's disease in a Chinese Han population. Dement Geriatr Cogn Disord 2004;18:115-9.
21. Matsui T, Morikawa Y, Tojo M et al. Cathepsin D polymorphism not associated with Alzheimer's disease in Japanese. Ann Neurol 2001;49:544-5.
22. Jhoo JH, Park WY, Kim KW et al. Lack of association of cathepsin D genetic polymorphism with Alzheimer's disease in Koreans. Arch Gerontol Geriatr 2005;41:121-7.
23. Schulte T, Böhringer S, Schöls L et al. Modulation of disease risk according to a cathepsin D/apolipoprotein E genotype in Parkinson's disease. J Neural Transm 2003;110:749-55.
24. Bishop MT, Kovacs GG, Sanchez-Juan P, Knight RS. Cathepsin D SNP associated with increased risk of variant Creutzfeldt-Jakob disease. BMC Med Genet 2008;9:31.
25. Kovacs GG, Sanchez-Juan P, Ströbel T et al. Cathepsin D (C224T) Polymorphism in Sporadic and Genetic Creutzfeldt-Jakob Disease. Alzheimer Dis Assoc Disord 2010;24:104-7.
26. Jeong BH, Lee KH, Lee YJ et al. Genetic Association of a Cathepsin D Polymorphism and Sporadic Creutzfeldt-Jakob Disease. Dement Geriatr Cogn Disord 2009;28:302-6.
27. Payton A, Holland F, Diggle P et al. Cathepsin D exon 2 polymorphism associated with general intelligence in a healthy older population. Mol Psychiatry 2003;8:14-8.
28. Tyynelä J, Sohar I, Sleat DE et al. A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration. EMBO J 2000;19:2786-92.
29. Lutgens SP, Cleutjens KB, Daemen MJ, Heeneman S. Cathepsin cysteine proteases in cardiovascular disease. FASEB J 2007;21:3029-41.
30. Tiwari M, Hemalatha T, Ganesan K et al. Myocardial ischemia and reperfusion injury in rats: lysosomal hydrolases and matrix metalloproteinases mediated cellular damage. Mol Cell Biochem 2008;312:81-91.
31. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn (DSM-IV), Washington, DC, 1994;143-7.
32. Roman GC, Tatemichi TK, Erkinjuntti T et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-60.
33. Hachinski VC, Iliff LD, Zilhka E et al. Cerebral blood flow in dementia. Arch Neurol 1975;32:632-7.
34. Majores M, Kolsch H, Bagli M et al. Cathepsin D: screening for new polymorphisms using single-strand conformation polymorphism analysis. Int J Mol Med 2002;9:185-7.
35. Jeong BH, Na HR, Bae JC et al. Absence of association between codon 129 and 219 polymorphisms of the prion protein gene and vascular dementia. Dement Geriatr Cogn Disord 2007;24:86-90.
36. Jeong BH, Lee KH, Lee YJ et al. Lack of association between PRNP 1368 polymorphism and Alzheimer's disease or vascular dementia. BMC Med Genet 2009;10:32.
37. Jeong BH, Nam JH, Lee YJ et al. Polymorphisms of the prion protein gene (PRNP) in a Korean population. J Hum Genet 2004;49:319-24.